Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease

AIMS: Epidemiological evidence for the link of interleukin 1 (IL-1) and its inhibition with cardiovascular diseases (CVDs) remains controversial. We aim to investigate the cardiovascular effects of IL-1 receptor antagonist (IL-1Ra) and underlying mechanisms. METHODS: Genetic variants identified from...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fangkun, Huangfu, Ning, Shen, Jiaxi, Su, Pengpeng, Zhu, Lujie, Cui, Hanbin, Yuan, Shuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628700/
https://www.ncbi.nlm.nih.gov/pubmed/37941911
http://dx.doi.org/10.3389/fendo.2023.1278273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628700/
https://www.ncbi.nlm.nih.gov/pubmed/37941911
http://dx.doi.org/10.3389/fendo.2023.1278273

Ejemplares similares